Related Experiment Videos
Management of tuberculosis in children
L M Voss1, ,
1Starship Children's Hospital, Auckland, New Zealand. ssinfect@ahsl.co.nz
Journal of Paediatrics and Child Health
|December 15, 2000
Insights
This paper outlines tuberculosis (TB) management guidelines, detailing drug regimens and evidence. It addresses drug-resistant TB, corticosteroids, and directly observed therapy for effective patient care.
Area of Science:
- Pulmonology and Infectious Diseases
- Microbiology and Immunology
Background:
- Tuberculosis (TB) remains a significant global health challenge, necessitating updated management strategies.
- Effective treatment relies on adherence to recommended drug regimens and understanding disease progression.
Framework:
- Provides evidence-based guidelines for managing both latent tuberculosis infection and active tuberculosis disease.
- Details general principles of TB care, including specific drug choices and treatment durations.
Implementation:
- Discusses the role of adjunctive therapies such as corticosteroids in specific TB cases.
- Highlights the importance of directly observed therapy (DOT) to improve treatment adherence and outcomes.
- Outlines strategies for managing patients with challenging drug-resistant tuberculosis (DR-TB).
Implications:
- Aims to standardize and improve the quality of tuberculosis care worldwide.
- Offers critical guidance for clinicians managing diverse TB patient populations, including those with drug resistance.
- Contributes to global efforts to control and eliminate tuberculosis through optimized treatment protocols.
Abstract:
This paper provides specific guidelines on the management of tuberculosis infection and disease, covering general principles, recommended drug regimens and discuss the evidence to support these. It also covers use of corticosteroids, intermittent therapy, directly observed therapy and an approach to the management of a patient with drug-resistant tuberculosis.